Hsien-Hsin Tung
Hsien-Hsin Tung
Unknown affiliation
Verified email at acryspharm.com
Title
Cited by
Cited by
Year
Crystallization of organic compounds: an industrial perspective
HH Tung, EL Paul, M Midler, JA McCauley
John Wiley & Sons, 2009
2362009
Direct design of pharmaceutical antisolvent crystallization through concentration control
GX Zhou, M Fujiwara, XY Woo, E Rusli, HH Tung, C Starbuck, O Davidson, ...
Crystal Growth & Design 6 (4), 892-898, 2006
1702006
Organic crystallization processes
EL Paul, HH Tung, M Midler
Powder technology 150 (2), 133-143, 2005
1352005
Solution concentration prediction for pharmaceutical crystallization processes using robust chemometrics and ATR FTIR spectroscopy
T Togkalidou, HH Tung, Y Sun, A Andrews, RD Braatz
Organic Process Research & Development 6 (3), 317-322, 2002
1062002
Formulation and stability of itraconazole and odanacatib nanoparticles: governing physical parameters
V Kumar, L Wang, M Riebe, HH Tung, RK Prud’homme
Molecular Pharmaceutics 6 (4), 1118-1124, 2009
1032009
Modeling liquid mass transfer in HIGEE separation process
HH TUNG, RSH MAH
Chemical Engineering Communications 39 (1-6), 147-153, 1985
1021985
Prediction of pharmaceutical solubility via NRTL-SAC and COSMO-SAC
HH Tung, J Tabora, N Variankaval, D Bakken, CC Chen
Journal of Pharmaceutical Sciences 97 (5), 1813-1820, 2008
822008
Parameter estimation and optimization of a loosely bound aggregating pharmaceutical crystallization using in situ infrared and laser backscattering measurements
T Togkalidou, HH Tung, Y Sun, AT Andrews, RD Braatz
Industrial & engineering chemistry research 43 (19), 6168-6181, 2004
822004
Industrial perspectives of pharmaceutical crystallization
HH Tung
Organic process research & development 17 (3), 445-454, 2013
682013
Image-analysis-based method for 3D crystal morphology measurement and polymorph identification using confocal microscopy
MR Singh, J Chakraborty, N Nere, HH Tung, S Bordawekar, ...
Crystal growth & design 12 (7), 3735-3748, 2012
482012
Formation and resolution of ibuprofen lysinate
HH Tung, S Waterson, SD Reynolds
US Patent 4,994,604, 1991
451991
Processes and Apparatuses for the Production of Crystalline Organic Microparticle Compositions by Micro-Milling and Crystallization on Micro-Seed and Their Use
BK Johnson, HH Tung, I Lee, AS Cote, C Starbuck, M Midler
US Patent App. 12/282,043, 2009
432009
Effect of jet velocity on crystal size distribution from antisolvent and cooling crystallizations in a dual impinging jet mixer
M Jiang, YED Li, HH Tung, RD Braatz
Chemical Engineering and Processing: Process Intensification 97, 242-247, 2015
382015
Robust model reference controller
HH Tung
US Patent 4,769,766, 1988
361988
Calorimetric investigation of an exothermic reaction: Kinetic and heat flow modeling
RN Landau, DG Blackmond, HH Tung
Industrial & engineering chemistry research 33 (4), 814-820, 1994
271994
Fractionating condensation and evaporation in plate‐fin devices
HH Tung, JF Davis, RSH Mah
AIChE journal 32 (7), 1116-1124, 1986
221986
Screening crystal morphologies from crystal structure
MR Singh, P Verma, HH Tung, S Bordawekar, D Ramkrishna
Crystal growth & design 13 (4), 1390-1396, 2013
212013
Process for 3-(2-(7-chloro-2-quinolinyl) ethenyl)-benzaldehyde
HH Tung, DM Hobbs
US Patent 5,869,673, 1999
211999
Potassium salt of an HIV integrase inhibitor
KM Belyk, HG Morrison, AJ Mahajan, DJ Kumke, HH Tung, L Wai, ...
US Patent 7,754,731, 2010
202010
Selective removal of a pharmaceutical process impurity using a reactive resin
CJ Welch, M Biba, A Drahus, DA Conlon, HH Tung, P Collins
Journal of liquid chromatography & related technologies 26 (12), 1959-1968, 2003
202003
The system can't perform the operation now. Try again later.
Articles 1–20